Summary
The use of restriction fragment length polymorphism studies for prenatal exclusion of OTC deficiency in a carrier mother is reported.
Similar content being viewed by others
References
Becroft, D. M. O., Barry, D. M. J., Webster, D. R. and Simmonds, H. A. Failure of protein loading tests to identify heterozygosity for ornithine carbamoyltransferase deficiency.J. Inher. Metab. Dis. 7 (1984) 157–159
Holzgreve, W. and Globus, M. S. Prenatal diagnosis of ornithine transcarbamylase deficiency utilizing fetal liver biopsy.Am. J. Hum. Genet. 36 (1984) 320–328
Spencer, E. J., Maddalena, A., O'Brien, W. E., Fernbach, S. D., Batshaw, M. L., Leonard, C. O. and Beaudet, A. Prenatal diagnosis and heterozygote detection by DNA analysis in ornithine transcarbamylase deficiency.J. Pediatr. 114 (1989) 582–588
Wendel, U., Wilichowski, E., Schmidtke, J. and Bachmann, C. DNA analysis of ornithine transcarbamylase deficiency.Eur. J. Pediatr. 147 (1988) 368–371
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liechti, S., Dionisi Vici, C., Bachmann, C. et al. Prenatal exclusion of ornithine transcarbamylase (OTC) by using RFLP analysis. J Inherit Metab Dis 13, 888–890 (1990). https://doi.org/10.1007/BF01800215
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01800215